-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On July 20, Jingfeng Pharmaceutical issued an announcement stating that its subsidiary Jinrui Pharmaceutical had received the "Drug Supplementary Application Approval Notice" for irinotecan hydrochloride injection approved and issued by the National Medical Products Administration.
Irinotecan hydrochloride injection is suitable for the treatment of patients with advanced colorectal cancer.
Irinotecan is a derivative of camptothecin, a topoisomerase specifically acts on the I